Responses
Commentary
Predicting relapse in patients with inflammatory bowel disease: what is the role of biomarkers?
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 18 April 2016
- Published on: 18 April 2016Inflammatory Biomarkers Predict Relapse in IBDShow More
Dear Editor,
After reading the paper presented by Costa et al. [1] in this issue of Gut and the additional commentary by Pardi and Sandborn [2] we would like to underscore the potential importance of biomarkers to assess intestinal inflammation and we would like to add a clarification on the faecal calprotectin assay.
We agree with Pardi and Sandborn that other serologic markers have not demonstrated clinical u...
Conflict of Interest:
None declared.